Lanham O'Dell & Company, Inc. Amgen Inc Transaction History
Lanham O'Dell & Company, Inc.
- $276 Million
- Q4 2025
A detailed history of Lanham O'Dell & Company, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Lanham O'Dell & Company, Inc. holds 745 shares of AMGN stock, worth $254,573. This represents 0.09% of its overall portfolio holdings.
Number of Shares
745
Previous 744
0.13%
Holding current value
$254,573
Previous $209,000
21.53%
% of portfolio
0.09%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,309Shares Held
428MCall Options Held
6.12MPut Options Held
5.85M-
Vanguard Group Inc Valley Forge, PA53.9MShares$18.4 Billion0.24% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$10 Billion0.3% of portfolio
-
Capital International Investors Los Angeles, CA19.2MShares$6.56 Billion0.92% of portfolio
-
Capital World Investors Los Angeles, CA18.8MShares$6.42 Billion0.76% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $183B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...